Literature DB >> 25410590

Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study.

Md Jamal Uddin1, Rolf H H Groenwold, Tjeerd P van Staa, Anthonius de Boer, Svetlana V Belitser, Arno W Hoes, Kit C B Roes, Olaf H Klungel.   

Abstract

PURPOSE: Prior event rate ratio (PERR) adjustment method has been proposed to control for unmeasured confounding. We aimed to assess the performance of the PERR method in realistic pharmacoepidemiological settings.
METHODS: Simulation studies were performed with varying effects of prior events on the probability of subsequent exposure and post-events, incidence rates, effects of confounders, and rate of mortality/dropout. Exposure effects were estimated using conventional rate ratio (RR) and PERR adjustment method (i.e. ratio of RR post-exposure initiation and RR prior to initiation of exposure).
RESULTS: In the presence of unmeasured confounding, both conventional and the PERR method may yield biased estimates, but PERR estimates appear generally less biased estimates than the conventional method. However, when prior events strongly influence the probability of subsequent exposure, the exposure effect from the PERR method was more biased than the conventional method. For instance, when the effect of prior events on the exposure was RR = 1.60, the effect estimate from the PERR method was RR = 1.13 and from the conventional method was RR = 2.48 (true exposure effect, RR = 2). In all settings, the variation of the estimates was larger for the PERR method than for the conventional method.
CONCLUSION: The PERR adjustment method can be applied to reduce bias as a result of unmeasured confounding. However, only in particular situations, it can completely remove the bias as a result of unmeasured confounding. When applying this method, theoretical justification using available clinical knowledge for assumptions of the PERR method should be provided.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  bias; epidemiology; pharmacoepidemiology; post-event; prior event; rate ratio; simulation; unmeasured confounding

Mesh:

Year:  2014        PMID: 25410590     DOI: 10.1002/pds.3724

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  12 in total

Review 1.  Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.

Authors:  Md Jamal Uddin; Rolf H H Groenwold; Mohammed Sanni Ali; Anthonius de Boer; Kit C B Roes; Muhammad A B Chowdhury; Olaf H Klungel
Journal:  Int J Clin Pharm       Date:  2016-04-18

2.  Impact of pioglitazone regulatory withdrawal on antidiabetic drug use and health in diabetic patients.

Authors:  Antoine Pariente; Yohann Mansiaux; Ana Jarné; Francesco Salvo; Cécile Pageot; Julien Bezin; Andy Smith; Bernard Bégaud
Journal:  Eur J Clin Pharmacol       Date:  2017-09-02       Impact factor: 2.953

3.  Characteristics of Children Prescribed Antipsychotics: Analysis of Routinely Collected Data.

Authors:  Sinead Brophy; Jonathan Kennedy; Fabiola Fernandez-Gutierrez; Ann John; Robert Potter; Christine Linehan; Michael Kerr
Journal:  J Child Adolesc Psychopharmacol       Date:  2018-02-27       Impact factor: 2.576

4.  Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.

Authors:  Fatmah Othman; Colin J Crooks; Timothy R Card
Journal:  BMJ       Date:  2016-11-15

5.  Prior event rate ratio adjustment for hidden confounding in observational studies of treatment effectiveness: a pairwise Cox likelihood approach.

Authors:  Nan Xuan Lin; William Edward Henley
Journal:  Stat Med       Date:  2016-08-01       Impact factor: 2.373

6.  Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study.

Authors:  Michael Dennis; Laura Shine; Ann John; Amanda Marchant; Joanna McGregor; Ronan A Lyons; Sinead Brophy
Journal:  Neurol Ther       Date:  2017-01-04

7.  Proton-Pump Inhibitors and Fragility Fractures in Vulnerable Older Patients.

Authors:  Jan Zirk-Sadowski; Jane A Masoli; W David Strain; Joao Delgado; William Henley; Willy Hamilton; David Melzer; Alessandro Ble
Journal:  Am J Gastroenterol       Date:  2017-03       Impact factor: 10.864

8.  Proton-Pump Inhibitors and Long-Term Risk of Community-Acquired Pneumonia in Older Adults.

Authors:  Jan Zirk-Sadowski; Jane A Masoli; Joao Delgado; Willie Hamilton; W David Strain; William Henley; David Melzer; Alessandro Ble
Journal:  J Am Geriatr Soc       Date:  2018-04-20       Impact factor: 5.562

9.  Assessing the prior event rate ratio method via probabilistic bias analysis on a Bayesian network.

Authors:  Edward W Thommes; Salaheddin M Mahmud; Yinong Young-Xu; Julia Thornton Snider; Robertus van Aalst; Jason K H Lee; Yuliya Halchenko; Ellyn Russo; Ayman Chit
Journal:  Stat Med       Date:  2019-12-01       Impact factor: 2.373

10.  The Effect of Buprenorphine on Human Immunodeficiency Virus Viral Suppression.

Authors:  Jongyeon Kim; Catherine R Lesko; Anthony T Fojo; Jeanne C Keruly; Richard D Moore; Geetanjali Chander; Bryan Lau
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 20.999

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.